Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients

NCT05481242 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT05481242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05481242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
Lead sponsor
Shengjing Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2011
Completion date
December 31, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deterioration, clinical, pulmonary embolism and thrombosis